Jennifer Mann

T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma

Lekha Mikkilineni, Elisabet E. Manasanch, Norris Lam et al. · Blood · 2019 · 45 citations

Histiocytic medullary reticulosis following acute lymphoblastic leukemia

C. M. Starkie, M.W. Kenny, Jennifer Mann et al. · Cancer · 1981 · 40 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, 2-Year-old Male +11

Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial

Jennifer N. Brudno, Danielle Natrakul, Jeremiah Karrs et al. · Blood Advances · 2023 · 24 citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, Refractory Cd30-expressing Lymphomas +14

Deep and Durable Remissions of Relapsed Multiple Myeloma on a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain

Lekha Mikkilineni, Elisabet E. Manasanch, Danielle Vanasse et al. · Blood · 2020 · 19 citations

Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain

Lekha Mikkilineni, Danielle Natrakul, Norris Lam et al. · Molecular Therapy · 2023 · 13 citations · Full text

Cancer Immunosurveillance, Autoimmune Disease, T Cells +9